BioLineRx

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$0.18-$1.64
Market Cap
$17M
Shares Short
921,883

Financials

See more
Revenue (12 Mos)
$17M
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$0.30

News

See more

Yahoo Finance • 2 years ago

BioLineRx to Report First Quarter 2023 Results on May 24, 2023

Yahoo Finance • 2 years ago

BioLineRx Announces Publication in Nature Medicine of its GENESIS Phase 3 Clinical Trial Data Evaluating Motixafortide and G-CSF in Stem Cell Mobilization for Autologous Transplantation in Multiple Myeloma

Yahoo Finance • 2 years ago

BLRX 集體訴訟截止日期：業界領先的投資者權益法律事務所 ROSEN 鼓勵 BioLineRx Ltd. 投資者在本所提起證券集體訴訟的重要截止日期 3 月 6 日前尋求法律意見 – BLRX

Yahoo Finance • 2 years ago

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Avaya, BioLineRx, Enovix, and Southwest Airlines and Encourages Investors to Contact the Firm

About

Address
Modi?in Technology Park, Hevel Modi'in, Israel, 7177871
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
79